Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 2
2005 3
2006 9
2007 1
2008 4
2009 3
2010 4
2011 3
2012 1
2013 1
2014 5
2015 2
2016 3
2017 4
2018 6
2019 1
2020 4
2021 5
2022 6
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas.
Niborski LL, Gueguen P, Ye M, Thiolat A, Ramos RN, Caudana P, Denizeau J, Colombeau L, Rodriguez R, Goudot C, Luccarini JM, Soudé A, Bournique B, Broqua P, Pace L, Baulande S, Sedlik C, Quivy JP, Almouzni G, Cohen JL, Zueva E, Waterfall JJ, Amigorena S, Piaggio E. Niborski LL, et al. Among authors: cohen jl. Nat Commun. 2022 Jun 29;13(1):3739. doi: 10.1038/s41467-022-31504-z. Nat Commun. 2022. PMID: 35768432 Free PMC article.
Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology.
Salomon BL, Leclerc M, Tosello J, Ronin E, Piaggio E, Cohen JL. Salomon BL, et al. Among authors: cohen jl. Front Immunol. 2018 Mar 12;9:444. doi: 10.3389/fimmu.2018.00444. eCollection 2018. Front Immunol. 2018. PMID: 29593717 Free PMC article. Review.
Author Correction: CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas.
Niborski LL, Gueguen P, Ye M, Thiolat A, Ramos RN, Caudana P, Denizeau J, Colombeau L, Rodriguez R, Goudot C, Luccarini JM, Soudé A, Bournique B, Broqua P, Pace L, Baulande S, Sedlik C, Quivy JP, Almouzni G, Cohen JL, Zueva E, Waterfall JJ, Amigorena S, Piaggio E. Niborski LL, et al. Among authors: cohen jl. Nat Commun. 2023 May 30;14(1):3127. doi: 10.1038/s41467-023-38931-6. Nat Commun. 2023. PMID: 37253849 Free PMC article. No abstract available.
TNFR2: The new Treg switch?
Cohen JL, Wood KJ. Cohen JL, et al. Oncoimmunology. 2017 Sep 21;7(1):e1373236. doi: 10.1080/2162402X.2017.1373236. eCollection 2017. Oncoimmunology. 2017. PMID: 29296530 Free PMC article.
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression.
Ponzo M, Debesset A, Cossutta M, Chalabi-Dchar M, Houppe C, Pilon C, Nicolas-Boluda A, Meunier S, Raineri F, Thiolat A, Nicolle R, Maione F, Brundu S, Cojocaru CF, Bouvet P, Bousquet C, Gazeau F, Tournigand C, Courty J, Giraudo E, Cohen JL, Cascone I. Ponzo M, et al. Among authors: cohen jl. Cancers (Basel). 2022 Aug 31;14(17):4265. doi: 10.3390/cancers14174265. Cancers (Basel). 2022. PMID: 36077801 Free PMC article.
Pathologic Response to Neoadjuvant Sequential Chemoradiation Therapy in Locally Advanced Breast Cancer: Preliminary, Translational Results from the French Neo-APBI-01 Trial.
To NH, Gabelle-Flandin I, Luong TMH, Loganadane G, Ouidir N, Boukhobza C, Grellier N, Verry C, Thiolat A, Cohen JL, Radosevic-Robin N, Belkacemi Y. To NH, et al. Among authors: cohen jl. Cancers (Basel). 2023 Mar 29;15(7):2030. doi: 10.3390/cancers15072030. Cancers (Basel). 2023. PMID: 37046691 Free PMC article.
IL4I1 binds to TMPRSS13 and competes with SARS-CoV-2 spike.
Gatineau J, Nidercorne C, Dupont A, Puiffe ML, Cohen JL, Molinier-Frenkel V, Niedergang F, Castellano F. Gatineau J, et al. Among authors: cohen jl. Front Immunol. 2022 Sep 5;13:982839. doi: 10.3389/fimmu.2022.982839. eCollection 2022. Front Immunol. 2022. PMID: 36131918 Free PMC article.
66 results